BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17109386)

  • 1. Lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia treated with continuous renal replacement therapy.
    Gajra A; Vajpayee N; Smith A; Poiesz BJ; Narsipur S
    Am J Hematol; 2007 May; 82(5):391-3. PubMed ID: 17109386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.
    Dager WE; White RH
    Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous haemofiltration with r-hirudin (lepirudin) as anticoagulant in a patient with heparin induced thrombocytopenia (HIT II).
    Schneider T; Heuer B; Deller A; Boesken WH
    Wien Klin Wochenschr; 2000 Jun; 112(12):552-5. PubMed ID: 10953874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis.
    Fischer KG; van de Loo A; Böhler J
    Kidney Int Suppl; 1999 Nov; (72):S46-50. PubMed ID: 10560805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy.
    Greinacher A
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):339-57. PubMed ID: 15151481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies.
    Mudaliar JH; Liem TK; Nichols WK; Spadone DP; Silver D
    J Vasc Surg; 2001 Jul; 34(1):17-20. PubMed ID: 11436069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lepirudin for cardiopulmonary bypass surgery in a patient with terminal renal insufficiency and acute heparin-induced thrombocytopenia.
    Riess FC; Dobritzsch B; Kormann J
    Thorac Cardiovasc Surg; 2006 Mar; 54(2):140-2. PubMed ID: 16541359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
    Dager WE; Gosselin RC; Yoshikawa R; Owings JT
    Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
    Fabrizio MC
    J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term application of lepirudin on chronic haemodialysis over 34 months after heparin-induced thrombocytopenia.
    Gay BE; Räz HR; Schmid HR; Beer JH
    Nephrol Dial Transplant; 2007 Jun; 22(6):1790-1. PubMed ID: 17395662
    [No Abstract]   [Full Text] [Related]  

  • 12. Developing an algorithm for treating heparin-induced thrombocytopenia.
    McIntosh BA
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):216-22. PubMed ID: 16163184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
    Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
    Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage late plasmapheresis in a patient with pulmonary embolism caused by heparin-induced thrombocytopenia primarily resistant to danaparoid sodium and lepirudin.
    Antonijevic NM; Savic NB; Perunicic J; Kovac M; Mikovic D; Stanojevic M; Calija B; Milosevic RA; Obradovic SD; Vasiljevic Z
    J Clin Apher; 2006 Dec; 21(4):252-5. PubMed ID: 16933276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lepirudin treatment in a boy with suspected HIT II after surgery because of tetralogy of Fallot.
    Hanke CA; Barth K; Nakamura L; Budde U; Arnold R; Zieger B; Stiller B
    Hamostaseologie; 2009 May; 29(2):168-70. PubMed ID: 19404513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin?
    Seybert AL; Coons JC; Zerumsky K
    Pharmacotherapy; 2006 Feb; 26(2):229-41. PubMed ID: 16466327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of lepirudin in haemodialysis complicated with heparin-induced thrombocytopenia type II (HIT II)--dosage monitoring.
    Kassimatis TI; Apostolou T; Theodoridis T; El Ali M; Hadjiconstantinou V
    Nephrol Dial Transplant; 2006 Nov; 21(11):3341-2. PubMed ID: 16822790
    [No Abstract]   [Full Text] [Related]  

  • 19. Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis.
    Willey ML; de Denus S; Spinler SA
    Pharmacotherapy; 2002 Apr; 22(4):492-9. PubMed ID: 11939684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.